Barclays PLC Has $6.91 Million Stock Holdings in Oscar Health, Inc. (NYSE:OSCR)

Barclays PLC lifted its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 217.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 325,818 shares of the company's stock after purchasing an additional 223,189 shares during the quarter. Barclays PLC owned 0.13% of Oscar Health worth $6,911,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Point72 Hong Kong Ltd acquired a new stake in Oscar Health during the second quarter worth about $78,000. Quest Partners LLC bought a new stake in shares of Oscar Health during the 2nd quarter worth approximately $93,000. KBC Group NV boosted its position in shares of Oscar Health by 41.2% during the 3rd quarter. KBC Group NV now owns 4,552 shares of the company's stock worth $97,000 after acquiring an additional 1,328 shares in the last quarter. Amalgamated Bank increased its stake in Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company's stock valued at $106,000 after acquiring an additional 1,458 shares during the last quarter. Finally, Optimum Investment Advisors acquired a new position in Oscar Health during the third quarter valued at approximately $142,000. 75.70% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, Director Thrive Partners Vii Growth Gp, purchased 420,819 shares of the business's stock in a transaction on Tuesday, November 12th. The shares were acquired at an average price of $13.68 per share, with a total value of $5,756,803.92. Following the completion of the transaction, the director now owns 5,452,081 shares of the company's stock, valued at $74,584,468.08. The trade was a 8.36 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Vice Chairman Joshua Kushner purchased 276,040 shares of the firm's stock in a transaction on Monday, November 11th. The shares were acquired at an average price of $13.58 per share, with a total value of $3,748,623.20. Following the completion of the acquisition, the insider now owns 5,031,262 shares in the company, valued at approximately $68,324,537.96. This trade represents a 5.80 % increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders purchased 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. 25.11% of the stock is owned by corporate insiders.

Oscar Health Trading Up 0.9 %

NYSE OSCR traded up $0.12 during trading hours on Thursday, reaching $13.50. The company's stock had a trading volume of 3,680,246 shares, compared to its average volume of 3,478,799. The firm has a fifty day simple moving average of $16.05 and a 200-day simple moving average of $17.48. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. Oscar Health, Inc. has a 52 week low of $7.80 and a 52 week high of $23.79. The stock has a market cap of $3.34 billion, a P/E ratio of -224.96 and a beta of 1.63.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same period in the previous year, the business posted ($0.29) EPS. Oscar Health's revenue was up 68.3% on a year-over-year basis. Equities analysts forecast that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. UBS Group started coverage on Oscar Health in a research note on Monday, October 7th. They issued a "neutral" rating and a $23.00 price target on the stock. Jefferies Financial Group began coverage on Oscar Health in a research report on Tuesday, December 10th. They issued an "underperform" rating and a $12.00 target price on the stock. Piper Sandler reissued an "overweight" rating and issued a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. Finally, Bank of America lowered shares of Oscar Health from a "neutral" rating to an "underperform" rating and decreased their price target for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $21.56.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.